The Her2/Neu (c-erbB-2) proto-oncogene is a transmembrane receptor tyrosine kinase that is clinically indicated in a number of carcinomas. Overexpression of the c-erbB-2 protein has been associated with ductal breast cancer, as well as pulmonary and gastric adenocarcinomas. A correlation between Her2 and p53 has also been documented, as overexpression of both proteins has been associated with early invasion and metastasis in bladder cancer.

SKU: N/A Category:
Image Variation SKU Price Quantity Add To Cart
HER2-neu-IHC002-Breast 0.1ml IHC002-100 278.00
Add to cart
HER2-neu-IHC002-Breast 1ml IHC002-1 1,924.00
Add to cart
HER2-neu-IHC002-Breast Positive Control 3 slides IHC002-PC 770.00
Add to cart


CE-IVD registered and supplied as a concentrate.   


Clone IHC002
Source Mouse Monoclonal
Positive Control Breast Carcinoma
Dilution Range 1:100 – 1:200


  1. Suthipintawong C, et al. Diagn Cytopathol. 1997; 17:127-33.
  2. Alexiev BA, et al. Gen Diagn Pathol. 1997; 142:271-9.
  3. Fernández Aceñero MJ, et al. Gen Diagn Pathol. 1997; 142:289-96.
  4. Koeppen HKW, et al. Histopathology. 2001; 38:96-104.
  5. Moch H, et al. Virchows Arch A Pathol Anat Histopathol. 1993; 423:329-34.
  6. Cetin B, et al. Transl Gastroenterol Hepatol. 2016; 1:59.

Additional information


0.1ml, 1ml, Positive Control 3 slides


Instructions for Use

Safety Data Sheet

Price Quote